 |
 Management of metabolic process of Calcium Oxalate Crystallization |
Research paper published in International Journal of Alternative And Complimentary Medicine
|
| |
|
 |
Market Size
More than $2.07 billion expended for evaluation and treatment of kidney stones
Unmet Medical Need
Recurrence of condition post-Lithotripsy.
...................................................
Lack of clinically proven botanical product for the condition. |
Targeted market
Sufferers of Kidney stones
Main Competitors
NSAIDS, Lithotripsy procedure |
Market Drivers:
More than 1 million new cases reported each year in USA for kidney stones.
...................................................
An estimated 10% people in USA will have a kidney stone at some point in their lives.
...................................................
Market flooded with anti-bacterial & UTI targeting products but unable to address lithotriptic effect. |
|
Indication |
Research Code |
Product Formulation & Characterization |
Pre-Clinical Proof of Concept |
Clinical Proof of concept |
Marketed as nutraceuticals |
Confirmatory Clinical Trial |
Ready to be marketed as medical food/ medical product |
Renal Stone |
E-US-02 |
|
| Research Highlight |
| • Double Blind, Placebo Controlled, ICH GCP Compliant trial
|
| • Treatment Duration: 90 days on 77 patients. |
|
|
|
Research Evidence:
Business Opportunity :
We would be happy to hear from marketing and distribution partners looking for Patented and scientifically validated product for Kidney Health.
It will be available in Canada, Kazakhstan by Dec 2012
|
